Comparative mRNA and microrna expression profiling of three genitourinary cancers reveals common hallmarks and Cancer-Specific molecular events

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Li, Xianxin ^a   Chen, Jiahao ^b,c   Hu, Xueda ^b,d,e   Huang, Yi ^a   Li, Zhizhong ^b,c   Zhou, Liang ^a   Tian, Zhijian ^b   Ma, Hongyu ^b   Wu, Zhiyun ^b   Chen, Maoshan ^b   Han, Zujing ^b   Peng, Zhiyu ^b   Zhao, Xiaokun ^f   Liang, Chaozhao ^g   Wang, Yong ^a   Sun, Liang ^a   Chen, Jing ^a   Zhao, Jun ^h   Jiang, Binghua ^h   Yang, Huanming ^b   Gui, Yaoting ^a   Cai, Zhiming ^a,i   Zhang, Xiuqing ^b   more..

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^b BGI SHENZHEN   (China)

^c SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^d Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^e UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^f CENTRAL SOUTH UNIVERSITY   (China)

^g ANHUI MEDICAL UNIVERSITY   (China)

^h SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

ⁱ SECOND PEOPLE S HOSPITAL OF SHENZHEN   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CELL RECEPTOR; DNA; EXTRACELLULAR MATRIX RECEPTOR; MESSENGER RNA; MICRORNA; PROTEIN P53; UNCLASSIFIED DRUG; TUMOR MARKER;

ARTICLE; BLADDER CARCINOMA; CALCIUM SIGNALING; CANCER GENETICS; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CELL MIGRATION; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE FUNCTION; GENOME ANALYSIS; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; KIDNEY CARCINOMA; MALE GENITAL SYSTEM FUNCTION; MOLECULAR PATHOLOGY; ONCOGENE; PHENOTYPE; SIGNAL TRANSDUCTION; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UROGENITAL TRACT CANCER; GENETICS; GENOMICS; MALE; METABOLISM; NEOPLASM; PATHOLOGY; TESTIS TUMOR; UROGENITAL TRACT TUMOR;

CARCINOMA, TRANSITIONAL CELL; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MALE; MICRORNAS; NEOPLASMS, GERM CELL AND EMBRYONAL; RNA, MESSENGER; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UROGENITAL NEOPLASMS;

EID: 79960728696     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022570     Document Type: Article

References (78)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Fangliu G, Yuli L, (2002) Changing status of genitourinary cancer in recent 50 years. Chinese Journal of Urology 2: 88-90.
3. Gaston KE, Grossman HB, (2010) Proteomic assays for the detection of urothelial cancer. Methods Mol Biol 641: 303-323.
4. Chow WH, Dong LM, Devesa SS, (2010) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7: 245-257.
5. McCredie M, (1994) Bladder and kidney cancers. Cancer Surv 19-20: 343-368.
6. Garner MJ, Turner MC, Ghadirian P, Krewski D, (2005) Epidemiology of testicular cancer: an overview. Int J Cancer 116: 331-339.
7. Ferlay J, Bray F, Pisani P, Parkin D, (2004) GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC cancerbase version 2.0.
8. Huyghe E, Matsuda T, Thonneau P, (2003) Increasing incidence of testicular cancer worldwide: a review. J Urol 170: 5-11.
9. Jacobs BL, Lee CT, Montie JE, (2010) Bladder cancer in 2010: how far have we come? CA Cancer J Clin 60: 244-272.
10. Rini BI, Campbell SC, Escudier B, (2009) Renal cell carcinoma. Lancet 373: 1119-1132.
11. Reuter VE, (2005) Origins and molecular biology of testicular germ cell tumors. Mod Pathol 18 (Suppl 2): S51-60.
12. Zhou L, Chen J, Li Z, Li X, Hu X, et al. (2010) Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma. PLoS One 5: e15224.
13. Han Y, Chen J, Zhao X, Liang C, Wang Y, et al. (2011) MicroRNA Expression Signatures of Bladder Cancer Revealed by Deep Sequencing. PLoS One 6: e18286.
14. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
15. Sheu BC, Chang WC, Cheng CY, Lin HH, Chang DY, et al. (2008) Cytokine regulation networks in the cancer microenvironment. Front Biosci 13: 6255-6268.
16. Altomare DA, Testa JR, (2005) Perturbations of the AKT signaling pathway in human cancer. Oncogene 24: 7455-7464.
17. Botchan A, Hauser R, Yogev L, Gamzu R, Paz G, et al. (1997) Testicular cancer and spermatogenesis. Hum Reprod 12: 755-758.
18. Thykjaer T, Workman C, Kruhoffer M, Demtroder K, Wolf H, et al. (2001) Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res 61: 2492-2499.
19. Garzon R, Calin GA, Croce CM, (2009) MicroRNAs in Cancer. Annu Rev Med 60: 167-179.
20. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
21. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, et al. (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169-1181.
22. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, et al. (2007) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Adv Exp Med Biol 604: 17-46.
23. Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS, (2009) Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 28: 3526-3536.
24. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601.
25. Park SM, Gaur AB, Lengyel E, Peter ME, (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907.
26. Soejima H, Nakagawachi T, Zhao W, Higashimoto K, Urano T, et al. (2004) Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer. Oncogene 23: 4380-4388.
27. Larson PS, Schlechter BL, King CL, Yang Q, Glass CN, et al. (2008) CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer. BMC Cancer 8: 68.
28. Bhat KM, Setaluri V, (2007) Microtubule-associated proteins as targets in cancer chemotherapy. Clin Cancer Res 13: 2849-2854.
29. Liu Z, Sall A, Yang D, (2008) MicroRNA: An emerging therapeutic target and intervention tool. Int J Mol Sci 9: 978-999.
30. Hahn WC, Weinberg RA, (2002) Rules for making human tumor cells. N Engl J Med 347: 1593-1603.
31. Harris SL, Levine AJ, (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24: 2899-2908.
32. Cavallaro U, Christofori G, (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4: 118-132.
33. Stetler-Stevenson WG, Aznavoorian S, Liotta LA, (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573.
34. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
35. Mocellin S, Wang E, Marincola FM, (2001) Cytokines and immune response in the tumor microenvironment. J Immunother 24: 392-407.
36. Mantovani A, Allavena P, Sica A, Balkwill F, (2008) Cancer-related inflammation. Nature 454: 436-444.
37. Kincaid-Smith P, (1972) Coagulation and renal disease. Kidney Int 2: 183-190.
38. Kaufman DS, Shipley WU, Feldman AS, (2009) Bladder cancer. Lancet 374: 239-249.
39. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98: 10869-10874.
40. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, et al. (2003) A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114: 323-334.
41. Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, et al. (2000) PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 14: 704-718.
42. Morikawa T, Hino R, Uozaki H, Maeda D, Ushiku T, et al. (2010) Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro. Hum Pathol 41: 1742-1748.
43. Hunt T, (1989) Maturation promoting factor, cyclin and the control of M-phase. Curr Opin Cell Biol 1: 268-274.
44. Liao H, Winkfein R, Mack G, Rattner J, Yen T, (1995) CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis. The Journal of cell biology 130: 507.
45. Cao JY, Liu L, Chen SP, Zhang X, Mi YJ, et al. (2010) Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma. Mol Cancer 9: 237.
46. Awakura Y, Nakamura E, Ito N, Kamoto T, Ogawa O, (2008) Methylation-associated silencing of TU3A in human cancers. Int J Oncol 33: 893-899.
47. Moscatello DK, Santra M, Mann DM, McQuillan DJ, Wong AJ, et al. (1998) Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest 101: 406-412.
48. Reed CC, Waterhouse A, Kirby S, Kay P, Owens RT, et al. (2005) Decorin prevents metastatic spreading of breast cancer. Oncogene 24: 1104-1110.
49. Reed CC, Gauldie J, Iozzo RV, (2002) Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin. Oncogene 21: 3688-3695.
50. Smith LT, Lin M, Brena RM, Lang JC, Schuller DE, et al. (2006) Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proc Natl Acad Sci U S A 103: 982-987.
51. Götze S, Feldhaus V, Traska T, Wolter M, Reifenberger G, et al. (2009) ECRG 4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer 9: 447.
52. Duband JL, Gimona M, Scatena M, Sartore S, Small JV, (1993) Calponin and SM22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. Differentiation 55: 1-11.
53. Islam AH, Ehara T, Kato H, Hayama M, Kobayashi S, et al. (2004) Calponin h1 expression in renal tumor vessels: correlations with multiple pathological factors of renal cell carcinoma. J Urol 171: 1319-1323.
54. Zheng Y, Vertuani S, Nystrom S, Audebert S, Meijer I, et al. (2009) Angiomotin-like protein 1 controls endothelial polarity and junction stability during sprouting angiogenesis. Circ Res 105: 260-270.
55. Liu J, Wang XB, Park DS, Lisanti MP, (2002) Caveolin-1 expression enhances endothelial capillary tubule formation. J Biol Chem 277: 10661-10668.
56. Griffoni C, Spisni E, Santi S, Riccio M, Guarnieri T, et al. (2000) Knockdown of caveolin-1 by antisense oligonucleotides impairs angiogenesis in vitro and in vivo. Biochem Biophys Res Commun 276: 756-761.
57. Joo HJ, Oh DK, Kim YS, Lee KB, Kim SJ, (2004) Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int 93: 291-296.
58. Campbell L, Gumbleton M, Griffiths DF, (2003) Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma. Br J Cancer 89: 1909-1913.
59. Baluk P, Hashizume H, McDonald DM, (2005) Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15: 102-111.
60. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
61. Boehm M, Slack FJ, (2006) MicroRNA control of lifespan and metabolism. Cell Cycle 5: 837-840.
62. Seitz H, Youngson N, Lin SP, Dalbert S, Paulsen M, et al. (2003) Imprinted microRNA genes transcribed antisense to a reciprocally imprinted retrotransposon-like gene. Nat Genet 34: 261-262.
63. Lee Y, Jeon K, Lee JT, Kim S, Kim VN, (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21: 4663-4670.
64. Olson P, Lu J, Zhang H, Shai A, Chun MG, et al. (2009) MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev 23: 2152-2165.
65. Dykxhoorn DM, Wu Y, Xie H, Yu F, Lal A, et al. (2009) miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 4: e7181.
66. Draheim KM, Chen HB, Tao Q, Moore N, Roche M, et al. (2010) ARRDC3 suppresses breast cancer progression by negatively regulating integrin beta4. Oncogene 29: 5032-5047.
67. Pallante P, Federico A, Berlingieri MT, Bianco M, Ferraro A, et al. (2008) Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer. Cancer Res 68: 6770-6778.
68. Karamitopoulou E, Pallante P, Zlobec I, Tornillo L, Carafa V, et al. (2010) Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer. Eur J Cancer 46: 1438-1444.
69. Tam L, McGlynn LM, Traynor P, Mukherjee R, Bartlett JM, et al. (2007) Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer. Br J Cancer 97: 378-383.
70. Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, et al. (2005) Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene 24: 4442-4449.
71. Saxena NK, Sharma D, Ding X, Lin S, Marra F, et al. (2007) Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res 67: 2497-2507.
72. Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, et al. (2001) SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 28: 29-35.
73. Audic S, Claverie JM, (1997) The significance of digital gene expression profiles. Genome Res 7: 986-995.
74. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B (Methodological) 57: 289-300.
75. Eisen MB, Spellman PT, Brown PO, Botstein D, (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95: 14863-14868.
76. Maragkakis M, Reczko M, Simossis VA, Alexiou P, Papadopoulos GL, et al. (2009) DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res 37: W273-276.
77. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
78. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.